Back to Search
Start Over
Editorial: Is vedolizumab the preferred biologic therapy for biologic‐naïve patients with ulcerative colitis?
- Source :
-
Alimentary Pharmacology & Therapeutics . Sep2023, Vol. 58 Issue 5, p546-547. 2p. - Publication Year :
- 2023
-
Abstract
- LINKED CONTENT: This article is linked to Bokemeyer et al paper. To view this article, visit https://doi.org/10.1111/apt.17616 [ABSTRACT FROM AUTHOR]
- Subjects :
- *ULCERATIVE colitis
*BIOTHERAPY
*VEDOLIZUMAB
Subjects
Details
- Language :
- English
- ISSN :
- 02692813
- Volume :
- 58
- Issue :
- 5
- Database :
- Academic Search Index
- Journal :
- Alimentary Pharmacology & Therapeutics
- Publication Type :
- Academic Journal
- Accession number :
- 169875474
- Full Text :
- https://doi.org/10.1111/apt.17628